SELLAS Life Sciences (SLS) 10-Q2009 Q1 Quarterly report

Filed: 15 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: adversely, APB, asset, avoid, commitment, commonly, consecutive, declared, deemed, diligence, DiPalma, dispose, disposition, distribution, economic, electronically, enhance, environment, event, exceed, exist, existing, exit, expenditure, flow, Global, headcount, high, house, impaired, impairment, inadvertent, inflammatory, Interactive, Legend, liability, liquidity, low, lowest, main, Master, multiple, notice, objective, Orderly, piggyback, post, posted, preferred, preserve, principle, promptly, publicly, quality, recent, request, scope, SEDA, Significantly, site, SPV, Standby, Stephen, stringent, structuring, technique, Tod, today, transaction, volume, Web, Woolf, YA, Yorkville

Removed: accrued, adequate, allocated, allocation, amortized, antidilutive, applicability, Argonaut, assessment, assumed, August, balance, beginning, book, CEO, CFO, charged, choose, classified, combination, computation, consolidated, continuing, coupon, deferred, Delaware, delivered, direct, disaggregated, discount, elimination, entity, evaluate, experience, extending, February, Federal, firm, formation, hand, hired, hold, improve, inactive, incorporated, independent, indirect, individual, initially, licensed, limited, maturity, measure, measured, multiplier, nature, neurodegenerative, nonrefundable, November, October, offset, operated, partially, party, percentage, performed, printing, prospective, ratified, reached, realized, received, recognize, recoverability, rent, reproduction, retained, revised, salary, September, short, spent, support, transferred, Treasury, Unrealized, working

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SLS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.1

March 5, 2009

Tod Woolf, Ph.D.
RXi Pharmaceuticals Corporation
60 Prescott St.
Worcester, MA 01609

Subject: RXi Pharmaceuticals/Newgate Properties Lease Amendment

Dear Tod,

Per the discussions with Eric Overstrom, Director of the WPI Life Sciences and Bioengineering Center (Newgate Properties, LLC), this letter is to serve as an amendment to the Lease between RXi Pharmaceuticals Corporation and Newgate Properties, LLC dated September 25, 2007, including all amendments and the extension thereof.

Beginning March 5, 2009, RXi Pharmaceuticals Corporation agrees to add to their premises the remaining Option Space shown in Exhibit D of the existing Lease. Newgate Properties, LLC has agreed to waive the requirement of 60 days notice for this space. This space consists of the western most lab pod on 3rd floor containing 610 usable square feet of laboratory space. Shared access to GP3238 is also provided. Per the existing Lease terms, the rent will increase by a rate of $34.00 per square foot per annum ($1,728.33 per month). Total monthly basic rent will be $19,130.66 beginning March 5, 2009, effective through the remainder of the Lease term.

By signing this letter, we agree to the above terms.

Very truly yours,

LANDLORD:
Newgate Properties, LLC



	By:	/s/ D’Anne Hurd
		D’Anne Hurd, Vice President and General Counsel
		Worcester Polytechnic Institute

TENANT:
RXi Pharmaceuticals Corporation
Acknowledged and Agreed to as of this 5th date of March, 2009



	By:	/s/ Tod Woolf
		Tod Woolf, Ph.D., President and CEO
		RXi Pharmaceuticals Corporation